Maricel Gómez‐Soler

Sanford Burnham Prebys Medical Discovery Institute

Also affiliated with Discovery Institute

Biochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Lipidation and PEGylation strategies to prolong the in vivo half-life of a nanomolar EphA4 receptor antagonist”.

Lipidation and PEGylation strategies to prolong the in vivo half-life of a nanomolar EphA4 receptor antagonist

European Journal of Medicinal Chemistry(2023)10.1016/j.ejmech.2023.115876

N/A

0.208DataRank · unranked

3 citations

Erika Olson, Elena Rubio de la Torre, Chun-Xia Zhao, Ilaria Lamberto, Dillon T. Flood +6 more

A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain

Journal of Biological Chemistry(2021)10.1016/j.jbc.2021.100876

N/A

0DataRank · unranked

14 citations

Maricel Gómez‐Soler, Zichen Wang, Kelly Karl, Elmer Zapata-Mercado, Marina P. Gehring +5 more

Ligands with different dimeric configurations potently activate the EphA2 receptor and reveal its potential for biased signaling

iScience(2022)10.1016/j.isci.2022.103870

N/A

0DataRank · unranked

29 citations

Marina P. Gehring, Bernhard C. Lechtenberg, Elmer Zapata-Mercado, Alyssa Ruelos, Mike W. Matsumoto +3 more